Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 263 results for "aurobindo"

Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US
Money Control

Pharma weekly wrap: Pharma stocks had tough week due to GST an...

The news highlights in the sector include first quarter results of Sun Pharma, Aurobindo Pharma, Cipla, Cadila Healthcare among others. The US pricing pressure looks more structural than a temporary event. Money Control, 4 days ago

92 images for aurobindo

Money Control, 1 week ago
Sify, 6 days ago
Money Control, 1 week ago
Money Control, 6 days ago
Money Control, 2 weeks ago
Money Control, 2 weeks ago
Money Control, 3 weeks ago
Money Control, 3 weeks ago
Money Today, 4 weeks ago
Money Control, 4 weeks ago
Money Control

Closing bell: Sensex rebounds after 2-day fall, Nifty ends above 10,050; IOC up 8%

Sun Pharma, Dr Reddy#39;s Labs, Lupin, Cipla, Aurobindo Pharma, Ambuja Cements, ONGC, Bharti Airtel, HDFC, Hero MotoCorp and Yes Bank declined up to 2 percent.
 Money Control1 week ago Market Live: Sensex rebounds 100 pts, Nifty opens above 9850; Aurobindo soars 8%  Money Control4 weeks ago Market Live: Sensex, Nifty hold on to gains; Pharma index top gainer  Money Control4 weeks ago Market Live: Sensex at new high, Nifty cools off after hitting 9900; Infosys up 2%  Money Control1 month ago
Money Control

Stocks in the news: Tata Motors, Aurobindo, Eicher Motors, NMDC, Varun, Natco Pharma

Tata Motors | Aurobindo Pharma | Eicher Motors | ONGC | HPCL | NALCO | NMDC | Jet Airways | Varun Beverages | NHPC | Jaypee Infratech | Piramal Enterprises | Man Infra | Mandhana Industries | Triveni Turbine | Max Financial Services | Ashoka Buildcon and ...
 Money Control6 days ago Stocks in the news: Tata Motors, Cadila Health, IRB Infra, Bharti Infratel, Bharat Forge  Money Control1 month ago Stocks in the news: RIL, Aurobindo, Tata Motors, Strides, Titan, Amtek Auto, Cadila  Money Control2 months ago
Money Control

Buy, Sell, Hold: 5 stocks that are being tracked by analysts today

Aurobindo, Eicher Motors and Bank of India, among others, are on the radar of investors on Thursday.
 Money Control6 days ago Buy, Sell, Hold: Analysts are tracking these 2 stocks today. Do you own them?  Money Control4 weeks ago
Money Control

Aurobindo Pharma Q1 net profit drops 11.4% to Rs 518 cr

Aurobindo Pharma, India#39;s third largest drug maker on Wednesday posted 11.4 percent decline to Rs.518.5 crore in net profit in the three month period ending 30 June on account of pricing pressure in US market. The company reported net profit of Rs.585 ...
 Money Control1 week ago Aurobindo Pharma Q1 net drops 11% at Rs 519 cr on low US sales, GST  Business Standard6 days ago Aurobindo Pharma Q4 net dips 4% to Rs 532 crore  Business Standard2 months ago

Aurobindo Pharma Q1 profit dips 11% at Rs 518 cr on low US sales, GST

BS ReporterHyderabad, 9 August: Hyderabad-based Aurobindo Pharma Limited has reported a 11.4 percent decline in consolidated net profit at Rs 518.5 crore for the quarter ended June, 2017 in the absence of growth from formulations business during the ...
 Business Standard6 days ago

Aurobindo Pharma first-quarter profit drops 11 percent, misses estimates

Drugmaker Aurobindo Pharma Ltd reported a 11 percent fall in quarterly profit, hurt by lower sales from its formulations business in the U.S. and pre-launch disruptions of a pan-India tax reform. Profit for the three months ended June 30 fell to 5.19 billion ...
 Sify6 days ago
Money Control

Aurobindo Pharma, Intas in race to buy Mallinckrodt#39;s US generic business

Aurobindo Pharma and Intas are in the race to buy UK-based Mallinckrodt#39;s generic drugs business in the US valued at USD 2 billion, this will be the biggest ever overseas acquisition for any Indian drug maker.
 Money Control1 week ago
Money Control

Buy Aurobindo Pharma, Hindustan Unilever, Tata Steel, IndusInd Bank: Ashwani Gujral

Ashwani Gujral of recommends buying Aurobindo Pharma, Hindustan Unilever, Tata Steel and IndusInd Bank.
 Money Control2 weeks ago Buy Reliance Industries, Aurobindo Pharma on dip: Gujral  Money Control1 month ago Buy Reliance Industries, Kotak Mahindra Bank, Aurobindo Pharma: Ashwani Gujral  Money Control1 month ago Buy Yes Bank, Indiabulls Housing, Auro Pharma, Capital First, RBL Bk: Ashwani Gujral  Money Control1 month ago

Expect EPS upgrades valuation rerating for Aurobindo: Surajit Pal

Aurobindo Pharma has gotten the United States Foods and Drug Administration (USFDA) approval for a generic drug that treats a chronic kidney disease. In an interview to CNBC-TV18, Surajit Pal of Prabhudas Lilladher spoke about the same.
 Money Control4 weeks ago Aurobindo Pharma surges higher on USFDA nod for Sevelamer tablets  Sify4 weeks ago Aurobindo Pharma stock rises up to 8% on USFDA nod to manufacture kidney disease drug  Money Today4 weeks ago Aurobindo Pharma receives final approval for Sevelamer Carbonate tablets  Business Standard4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less